Clinical Trial Update: Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing carvedilol versus verapamil in chronic heart failure due to non-ischemic cardiomyopathy is ongoing. Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Systolic Heart Failure

Drugs mentioned

• CARVEDILOL (Carvedilol)
• Verapamil (verapamil)

Snippet

Sponsor: Medical University of Silesia | Conditions: Systolic Heart Failure, Myocardial Disease | Phase 4 | Status: UNKNOWN